Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Please provide your email address to receive an email when new articles are posted on . A novel genetic test may provide clues to what caused a person’s sudden cardiac death. Testing can then be ...

The "Global Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, ...

Introduction Inherited cardiac conditions, including dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), may ...

Adopting early noninvasive cardiac testing is a cost-effective strategy for avoiding a future heart attack or death in patients with suspected acute coronary syndrome, according to a study published ...

Please provide your email address to receive an email when new articles are posted on . Cardiologists should work with experienced centers performing genetic testing to identify and manage inherited ...

For lower-risk patients with acute myocardial injury already ruled out for their chest pain, an increase in referrals for noninvasive cardiac testing (NICT) was not associated with improved outcomes, ...

A new study finds that cardiovascular diagnostic testing has yet to return to prepandemic levels in some regions of the world, and that excess pandemic-related stress among physicians and testing ...

New York, Aug. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Marker Testing Market Research Report by Type, by Product, by Disease, by Type of Testing - ...

DUBLIN--(BUSINESS WIRE)--The "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease ...

CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The cardiac marker testing industry is poised for significant advancements in the near future, driven by breakthroughs in diagnostic technologies and an ...